Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
Year: 2011
Type: article
Study design: Observational Study
Abstract: BACKGROUND: The exact overall incidence of sarcoma and sarcoma subtypes is not known. The objective of the present population-based study was to determine this incidence in a European region (Rhone-Alpes) of six million inhabitants, based on a central pathological review of the cases. METHODOLOGY/PRINCIPAL FINDINGS: From March 2005 to February 2007, pathology reports and tumor blocks were prospectively collected from the 158 pathologists of the Rhone-Alpes region. All diagnosed or suspected cases of sarcoma were collected, reviewed centrally, examined for molecular alterations and classified according to the 2002 World Health Organization classification. Of the 1287 patients screened during the study period, 748 met the criteria for inclusion in the study. The overall crude and world age-standardized incidence rates were respectively 6.2 and 4.8 per 100,000/year. Incidence rates for soft tissue, visceral and bone sarcomas were respectively 3.6, 2.0 and 0.6 per 100,000. The most frequent histological subtypes were gastrointestinal stromal tumor (18%; 1.1/100,000), unclassified sarcoma (16%; 1/100,000), liposarcoma (15%; 0.9/100,000) and leiomyosarcoma (11%; 0.7/100,000). CONCLUSIONS/SIGNIFICANCE: The observed incidence of sarcomas was higher than expected. This study is the first detailed investigation of the crude incidence of histological and molecular subtypes of sarcomas.
Source: PLoS ONE
Authors: Françoise Ducimetière, Antoine Lurkin, Dominique Ranchère-Vince, Anne-Valérie Decouvelaere, Michel Péoc'h, Luc Istier, Philippe Chalabreysse, Christine Muller, Laurent Alberti, Pierre-Paul Bringuier, Jean-Yves Scoazec, Anne-Marie Schott, Christophe Bergeron, Dominic Cellier, Jean-Yves Blay, Isabelle Ray-Coquard
Institutions: Université de Lyon, Centre Léon Bérard, Parcours santé systémique, Centre de Recherche en Cancérologie de Lyon, Biologie, ingénierie et imagerie pour l'Ophtalmologie, Centre Hospitalier Universitaire de Saint-Étienne, Université Jean Monnet, Université Jean Monnet, Inserm, Hospices Civils de Lyon, Hôpital Edouard Herriot, Institut d’Hématologie et d’Oncologie Pédiatrique, Merck Serono S.A.S. (France), Université Lumière Lyon 2
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
OpenAlex ID: W2048513224
